FAQ/Help |
Calendar |
Search |
Today's Posts |
06-09-2012, 09:58 PM | #1 | ||
|
|||
Senior Member
|
For those of you interested in using geographical differences in prevalence rates to try to get a greater understanding of PD, the paper by Pedro-Cuesta et al. is a must. It does for Spain what the paper by Willis does for the US.
Highlights: - north bad, south good; - identifies hot-spots. "Spatial distribution of Parkinson's disease mortality in Spain, 1989-1998, as a guide for focused aetiological research or health-care intervention" Jesús de Pedro-Cuesta, Eduard Rodríguez-Farré and Gonzalo Lopez-Abente BMC Public Health, vol 9, Dec 2009. http://www.biomedcentral.com/1471-2458/9/445 John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans | ALS News & Research | |||
occupations & geographical areas | ALS News & Research | |||
Teresa from Spain | Parkinson's Disease |